AI assistant
Sending…
SELLAS Life Sciences Group, Inc. — Director's Dealing 2011
Sep 28, 2011
33651_dirs_2011-09-27_89fea014-c0e1-4e2e-82da-1cb23881acc9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Galena Biopharma, Inc. (RXII)
CIK: 0001390478
Period of Report: 2011-09-24
Reporting Person: Khvorova Anastasia (Former CSO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-09-24 | Common Stock | A | 76923 | — | Acquired | 137482 | Direct |
More from SELLAS Life Sciences Group, Inc.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 12
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Jan 30
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9